WHO WE ARE
Bright Dent is a leading dental distribution company with its headquarter situated in Iraq/Erbil, which engages in the distribution and marketing of all categories of dental products and equipment supplies. Our products and services of multiple aspects are procured through rigorous care, and only from qualified, internationally recognized sources. We provide them for both public and private sectors, in addition to universities, dental laboratories, care centers, charities, and other healthcare institutions across Iraq.
Is One of the fastest growing dental companies. From 2017 to 2022 1200% capital growth rate. Aim to be number one in Iraq by 2025
Bright Dent was founded in 2017 and is registered in the Ministry of Health and Chamber of Commerce. We have great pride in our tightly held values and our successful partnerships with many international/reputable manufacturers and brands across the world. Our team of professionals privilege more than 10 years of experience, and we are totally committed to continue our legacy of business ethics and professionalism for the up-coming years.
Keep in touch
Activities and Academy
Irrigation protocol and canal shaping hands on course
Bright Dent Company was privileged to sponsor an enriching hands on course that was...
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Stay up-to-date with the latest news and broaden your knowledge about new scientific developments and how they can enhance your practice here!
Articles
News
Clinical advantages of systemic amoxicillin/metronidazole may be influenced by the severity of periodontitis and the age of the patient
Periodontitis, which is brought on by microbial biofilms, affects roughly 50% of the adult population in industrialized nations. Periodontitis-affected teeth may become inoperable and need to be extracted, which frequently necessitates pricey prosthetic...
The effect of periodontal pathogens on occurrence of further adverse CV events in patients with cardiovascular disease (CVD)
A moderate but independent risk factor for cardiovascular (CV) disease and progression has been identified as periodontitis. Numerous common risk factors are shared by the etiologies of those chronic and highly prevalent inflammatory diseases. Despite these...
Economist report on socio-economic effect of periodontitis and how eliminating gingivitis is most cost-effective strategy in Germany
According to a recent report on the financial and human cost of periodontitis, commissioned by the EFP and published by the Economist Intelligence Unit (EIU), a public-health strategy based on eliminating gingivitis (and preventing progression to periodontitis) would...
The EFP published the first formal evidence-based guideline, for treating stages I to III of periodontitis, in the Journal of Clinical Periodontology.
The EFP have recently published the first formal evidence-based guideline, for treating stages I to III of periodontitis. According to the 2018 edition of the perio classification of periodontal and peri-implant diseases and conditions, it contains 62...
Clinical advantages of systemic amoxicillin/metronidazole may be influenced by the severity of periodontitis and the age of the patient
Periodontitis, which is brought on by microbial biofilms, affects...
The effect of periodontal pathogens on occurrence of further adverse CV events in patients with cardiovascular disease (CVD)
A moderate but independent risk factor for cardiovascular (CV) disease and progression has been identified as periodontitis. Numerous common risk factors are shared by the etiologies of those chronic and highly prevalent inflammatory diseases. Despite these...
Economist report on socio-economic effect of periodontitis and how eliminating gingivitis is most cost-effective strategy in Germany
According to a recent report on the financial and human cost of periodontitis, commissioned by the EFP and published by the Economist Intelligence Unit (EIU), a public-health strategy based on eliminating gingivitis (and preventing progression to periodontitis) would...
The EFP published the first formal evidence-based guideline, for treating stages I to III of periodontitis, in the Journal of Clinical Periodontology.
The EFP have recently published the first formal evidence-based guideline, for treating stages I to III of periodontitis. According to the 2018 edition of the perio classification of periodontal and peri-implant diseases and conditions, it contains 62...
FACILITIES AND BUSINESS MODEL
A BRIDGE FROM DISCOVERY TO MARKET
Bright Dent has left its mark in the Iraqi market as one of the most trustful companies and has a proven track record in keeping pace with the rapidly growing health care sector. It operates and markets its products all over Iraq through its central and regional business units.
Nation-wide collaboration with dental supply stories in almost all cities and towns in Iraq, with a team of experts and professional doctors, all ensures the best for the sale and marketing of our suppliers’ products. Successful cooperation with both public and private sectors, universities, dental laboratories, and dental centers.
More than 10 years of experience and a wide range of relationships across the country.
We give a large support to our customers by providing highest quality products at an equitable price with the utmost of standards and top services.
Our imported products are all compliant to international standards of quality and manufacturing practices.
Bright Dent also provides its team several trainings and rewardeds regardless of race, ethnicity, color, religion, gender, and national origin.
A leading and one of the fastest growing companies in Iraq for the distribution of all categories of dental and laboratory supplies.
All Rights Reserved.